Publications dans lesquelles il/elle collabore avec Loreto Carmona Ortells (18)

2023

  1. Proposal for updating the Health Assessment Questionnaire

    Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272

2021

  1. Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

    Frontiers in Medicine, Vol. 8

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

2019

  1. The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity

    PLoS ONE, Vol. 14, Núm. 4

2017

  1. Corrigendum to “Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes (Seminars in Arthritis and Rheumatism (2017) 46(5) (609–614) (S0049017216303432) (10.1016/j.semarthrit.2016.10.002))

    Seminars in Arthritis and Rheumatism

  2. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 5, pp. 609-614

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)

    Rheumatology International

  2. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

    Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137

  3. The EULAR Outcome Measures Library: An evolutional database of validated patient-reported instruments

    Annals of the Rheumatic Diseases

  4. The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments

    Clinical and experimental rheumatology, Vol. 33, Núm. 6, pp. 910-916

2014

  1. Índices compuestos para evaluar la actividad de la enfermedad y el daño estructural en pacientes con lupus eritematoso: Revisión sistemática de la literatura

    Reumatologia Clinica

2013

  1. Development and validation of a new disease activity index as a numerical sum of four variables in patients with early arthritis

    Arthritis Care and Research, Vol. 65, Núm. 4, pp. 518-525

2011

  1. Clinical composite measures of disease activity for diagnosis and followup of undifferentiated peripheral inflammatory arthritis: A systematic review

    Journal of Rheumatology, Vol. 38, Núm. SUPPL. 87, pp. 48-53

  2. Diagnostic and prognostic value of genetics in undifferentiated peripheral inflammatory arthritis: A systematic review

    Journal of Rheumatology, Vol. 38, Núm. SUPPL. 87, pp. 38-44

  3. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 1, pp. 15-24

2010

  1. Influence of gender on treatment response in a cohort of patients with early rheumatoid arthritis in the area 2 of Madrid

    Reumatologia Clinica, Vol. 6, Núm. 3, pp. 134-140

2008

  1. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 5, pp. 769-775